Impact of rosuvastatin on atherosclerosis in people with HIV at moderate cardiovascular risk: a randomised, controlled trial
Janine M. Trevillyan(Alfred Health), Alexandra Calmy(University Hospital of Geneva), Cornelia Staehelin, Jennifer Hoy(The Alfred Hospital), Jan Fehr(University Hospital of Zurich), Anthony M. Dart(The Alfred Hospital), Matthias Cavassini(University of Zurich), Elizabeth Dewar(Alfred Health), Eldho Paul(Monash Health)
Cited by 10
Related Papers
Mpox in people with advanced HIV infection: a global case series
|The Lancet|2023|506